Cargando…
Optimizing Botox regimens in patients with adductor spasmodic dysphonia and essential tremor of voice: A 31‐year experience
OBJECTIVE: The purpose of this study was to quantitatively compare the effectiveness of unilateral and bilateral botulinum toxin A (BTX‐A) injections for mitigating undesirable weak/breathy voice quality and dysphagia for patients with adductor spasmodic dysphonia and/or essential tremor of voice (E...
Autores principales: | Stone, Amy, Powell, Maria E., Hamers, Kaitlyn, Fletcher, K. Charles, Francis, David O., Courey, Mark S., Netterville, James L., Garrett, C. Gaelyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575140/ https://www.ncbi.nlm.nih.gov/pubmed/36262464 http://dx.doi.org/10.1002/lio2.915 |
Ejemplares similares
-
Validity of intraoperative voice monitoring undergoing type 2 thyroplasty with titanium bridges for adductor spasmodic dysphonia
por: Sanuki, Tetsuji, et al.
Publicado: (2022) -
Post‐treatment clinical course following botulinum toxin injection therapy for adductor spasmodic dysphonia: Analysis of data from a placebo‐controlled, randomized, double‐blinded clinical trial in Japan
por: Hirose, Kahori, et al.
Publicado: (2021) -
Tridimensional assessment of adductor spasmodic dysphonia pre- and post-treatment with Botulinum toxin
por: Dejonckere, P. H., et al.
Publicado: (2011) -
Voice assessment of fat injection vs medialization laryngoplasty in nonparalytic dysphonia
por: Rapoport, Sarah K., et al.
Publicado: (2021) -
A visual analog scale for patient‐reported voice outcomes: The VAS voice
por: Naunheim, Matthew R., et al.
Publicado: (2019)